Skip to main content
Screener/Healthcare/Biotechnology

CYTK — Cytokinetics, Incorporated

NASDAQ
$76.97+2.67 (+3.60%)
Mid CapHealthcareFastest GrowingHigh ROELow Beta
$29.31
$80.20
$74.51
$78.80
EPS (TTM)$-6.84
P/E Ratio-9.43
Dividend Yield—
Market Cap$7.88B
Volume3.20M
Prev Close$74.29
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$19.4M-$206.0M$-1.6787.6%-1064.5%
Q4 '25$17.8M-$183.0M$-1.5083.9%-1030.9%
Q3 '25$1.9M-$306.2M$-2.55-38.4%-15815.0%
Q2 '25$66.8M-$134.4M$-1.1296.6%-201.2%
Q1 '25$1.6M-$161.4M$-1.36-6223.1%-10220.1%
Q4 '24$16.9M-$150.0M$-1.27-453.1%-886.3%
Q3 '24$463K-$160.5M$-1.36-18174.7%-34674.9%
Q2 '24$249K-$143.3M$-1.31-31866.7%-57557.4%
Get Your Daily Market Recap